Alnylam Pharmaceuticals
ALNY
#631
Rank
C$55.61 B
Marketcap
C$416.58
Share price
-1.01%
Change (1 day)
-0.35%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company